62856-0704
                        
                    
                            Lenvima
                        
                    
                                    Lenvatinib
                                
                            
                        
                    
                            CAPSULE
                        
                    
                                    Oral
                                
                            
                        
                    
                                     LENVATINIB
                                
                                
                                     4.0
                                
                                
                                     mg/1
                                
                                
                            
                        
                    
                                     62856-0704-30
                                
                                
                                     6 BLISTER PACK in 1 BOX, UNIT-DOSE (62856-704-30)  / 5 CAPSULE in 1 BLISTER PACK (62856-704-05) 
                                
                                
                                     Aug. 15, 2018
                                
                                
                                    Chemotherapy
                                
                            
                        
                    
                                    Tyrosine Kinase Inhibitor
                                
                            
                        
                    
                                    VEGFR, FGF, PDGFR, KIT, RET
                                
                            
                        
                    
                            In Use
                        
                     An official website of the United States government
 An official website of the United States government
		 Home
 Home 
                             
                    